Literature DB >> 11520526

Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children.

N A Cunliffe1, J S Gondwe, C D Kirkwood, S M Graham, N M Nhlane, B D Thindwa, W Dove, R L Broadhead, M E Molyneux, C A Hart.   

Abstract

BACKGROUND: Rotaviruses represent important causes of severe diarrhoea in early childhood. We examined the effect of HIV infection on the presentation and outcome of rotavirus gastroenteritis in Malawian children.
METHODS: Children younger than 5 years who were treated for acute gastroenteritis at the Queen Elizabeth Central Hospital in Blantyre from July, 1997, to June, 1999, were enrolled. Children with rotavirus diarrhoea, with and without HIV infection, were followed up for up to 4 weeks after hospital discharge. Rotavirus disease severity (assessed with a 20-point score), duration of rotavirus shedding, and seroresponse to rotavirus were compared between HIV-infected and HIV-uninfected children.
FINDINGS: 786 inpatients (median age 8 months, 271 [34%] of whom were HIV-1-infected) and 400 outpatients (median age 9 months, 65 [16%] of whom were HIV-infected) were enrolled. Rotavirus was detected less frequently among HIV-infected children (102 of 336 [30%]) than among HIV-uninfected children (348 of 850 [41%], (relative risk 0.71 [95% CI 0.53-0.87], p=0.0007). There were no differences in rotavirus disease severity for hospitalised children with and without HIV infection, but HIV-infected children were more likely to die during follow-up (11/50 [22%]) than HIV-uninfected children (0/61, p<0.0001). Of 29 HIV-infected and 45 HIV-uninfected children who completed follow-up, six (21%) HIV-infected children shed rotavirus, compared with two (4%) HIV-uninfected children (4.66 [1.01-21.51], p=0.05), but shedding was not associated with diarrhoea. Three-quarters of children exhibited a four-fold rise of serum IgG or IgA to rotavirus, which did not vary by HIV status.
INTERPRETATION: Malawian children with concomitant HIV infection resolved acute rotavirus infections. Rotavirus vaccine safety and immunogenicity in HIV-infected infants should now be determined.

Entities:  

Mesh:

Year:  2001        PMID: 11520526     DOI: 10.1016/s0140-6736(01)05706-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

Review 1.  Immunization of HIV infected children.

Authors:  Jagdish Chandra; Dinesh Yadav
Journal:  Indian J Pediatr       Date:  2012-02-10       Impact factor: 1.967

2.  The cost-effectiveness of rotavirus vaccination in Malawi.

Authors:  Stephen A Berry; Benjamin Johns; Chuck Shih; Andrea A Berry; Damian G Walker
Journal:  J Infect Dis       Date:  2010-09-01       Impact factor: 5.226

Review 3.  Management of gastrointestinal disorders in children with HIV infection.

Authors:  Alfredo Guarino; Eugenia Bruzzese; Giulio De Marco; Vittoria Buccigrossi
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

4.  History of rotavirus research in children in Malawi: the pursuit of a killer.

Authors:  Nigel Cunliffe; Desiree Wittel; Bagrey Ngwira
Journal:  Malawi Med J       Date:  2009-09       Impact factor: 0.875

Review 5.  Rotavirus infections and vaccines: burden of illness and potential impact of vaccination.

Authors:  Keith Grimwood; Stephen B Lambert; Richard J Milne
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

Review 6.  The role of prolonged viral gastrointestinal infections in the development of immunodeficiency-related enteropathy.

Authors:  Annick A J M van de Ven; David P Hoytema van Konijnenburg; Annemarie M J Wensing; Joris M van Montfrans
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

7.  Rotavirus antigen, cytokine, and neutralising antibody profiles in sera of children with and without HIV infection in Blantyre, Malawi.

Authors:  Jennifer J Hull; Nigel Cunliffe; Khuzwayo C Jere; Sung-Sil Moon; Yuhuan Wang; Umesh Parashar; Baoming Jiang
Journal:  Malawi Med J       Date:  2017-03       Impact factor: 0.875

8.  Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.

Authors:  Myron J Levin; Jane C Lindsey; Susan S Kaplan; Werner Schimana; Jody Lawrence; Monica M McNeal; Mutsa Bwakura-Dangarembizi; Anthony Ogwu; Evans M Mpabalwani; Paul Sato; George Siberry; Margaret Nelson; Darcy Hille; Geoffrey A Weinberg; Adriana Weinberg
Journal:  AIDS       Date:  2017-01-02       Impact factor: 4.177

9.  Prevalence and factors associated with rotavirus infection among children admitted with acute diarrhea in Uganda.

Authors:  Jane S Nakawesi; Eric Wobudeya; Grace Ndeezi; Edison A Mworozi; James K Tumwine
Journal:  BMC Pediatr       Date:  2010-09-24       Impact factor: 2.125

Review 10.  Immunization in patients with HIV infection: are practical recommendations possible?

Authors:  Brian Eley
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.